A Comparison of tilmicosin and ceftiofur for the treatment of bovine respiratory disease

Authors

  • Robert A. Smith College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078
  • Donald R. Gill Oklahoma State University, Stillwater, OK 74078
  • Michael T. VanKoevering Farmland Industries, Inc., Kansas City, MO 64116

DOI:

https://doi.org/10.21423/bovine-vol1994no28p35-37

Abstract

Bovine respiratory disease (BRD), or "Shipping Fever", continues to be the most costly disease of stocker and feeder cattle. Recent weaning, movement through auction markets, commingling and shipment are significant stressors. Recently received, stressed calves are particularly vulnerable to infection with respiratory viruses and bacteria, especially Pasteurella hemolytica. Morbidity rates in stocker calves of southeastern origin often exceed 50%, and mortality rates are commonly 2-4%. The objective of this study was to compare efficacy of tilmicosin and ceftiofur, the two drugs most recently approved by the FDA for treatment of BRD.

Author Biographies

Robert A. Smith, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078

McCasland Chair in Beef Health and Production

Donald R. Gill, Oklahoma State University, Stillwater, OK 74078

Regents Professor and Extension Animal Scientist

Cover image of the 28th Volume of the Bovine Practitioner: a photo of Pittsburgh from a cable care on the Duquesne Incline

Downloads

Published

1994-09-01

How to Cite

Smith, R. A., Gill, D. R., & VanKoevering, M. T. (1994). A Comparison of tilmicosin and ceftiofur for the treatment of bovine respiratory disease. The Bovine Practitioner, 1994(28), 35–37. https://doi.org/10.21423/bovine-vol1994no28p35-37

Issue

No. 28 (1994 September)

Section

Articles

Most read articles by the same author(s)